Geovax Labs Inc Stock OTC Bulletin Board
Equities
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 4.4M |
---|---|---|---|---|---|
Net income 2024 * | -31M | Net income 2025 * | - | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.01
x | P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.55% |
Latest transcript on Geovax Labs Inc
Managers | Title | Age | Since |
---|---|---|---|
David Dodd
CEO | Chief Executive Officer | 74 | 10-03-16 |
Mark Reynolds
DFI | Director of Finance/CFO | 62 | 06-09-30 |
Erica Raiden
CTO | Chief Tech/Sci/R&D Officer | - | 22-03-06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert McNally
BRD | Director/Board Member | 76 | 06-11-30 |
Randal Chase
BRD | Director/Board Member | 74 | 15-03-18 |
John Spencer
BRD | Director/Board Member | 83 | 06-09-27 |
1st Jan change | Capi. | |
---|---|---|
+51.38% | 63.85B | |
-2.32% | 41.83B | |
+40.01% | 40.47B | |
-10.22% | 27.17B | |
+13.32% | 26.52B | |
-21.49% | 18.69B | |
+2.77% | 12.73B | |
+21.44% | 12.11B | |
+27.84% | 12.07B |